25 May 2013
Keywords: iroko, acquires, rights, merck, co, cv, compound
Article | 04 February 2008
Philadelphia, USA-based Iroko Pharmaceuticals has acquired all non-US commercial rights to Aggrastat (tirofiban HCl) from drug major Merck &
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
4 February 2008
24 May 2013
© 2013 thepharmaletter.com